Best Stocks Under $3 | Low-Priced Stocks for $3 or Less

1. Ur Energy NYSEAMERICAN:URG

$1.41 -0.12 (-7.84%)

As of 08/28/2026 04:10 PM Eastern

Ur-Energy Inc engages in the acquisition, exploration, development, and operation of uranium mineral properties. The company holds interests in 12 projects located in the United States. More about Ur Energy

Market Capitalization: $560.31 million
Consensus Rating: Buy
Consensus Price Target: $2.32 (+64.3% Upside)
Volume: 5.22 million shares
Average Volume: 6.01 million shares
Today's Range: $1.41
▼
$1.54

2. CuriosityStream NASDAQ:CURI

$2.61 +0.05 (+1.95%)

As of 08/28/2026 04:00 PM Eastern

CuriosityStream Inc operates as a factual content streaming service and media company. The company provides premium video and audio programming services in various categories of factual entertainment, including science, history, society, nature, lifestyle, and technology through direct subscription video on-demand (SVoD) platforms accessible by internet connected devices, or indirectly via distribution partners who deliver CuriosityStream content via distributor's platform or system, as well as through bundled content licenses for SVoD and linear offerings, talks and courses, and partner bulk sales. More about CuriosityStream

Market Capitalization: $154.87 million
P/E Ratio: 261.00
Consensus Rating: Buy
Consensus Price Target: $5.50 (+110.7% Upside)
Volume: 1.03 million shares
Average Volume: 2.12 million shares

3. Nouveau Monde Graphite NYSE:NMG

$1.45 -0.06 (-4.03%)

As of 08/28/2026 03:57 PM Eastern

Nouveau Monde Graphite Inc engages in the acquisition, exploration, development, and evaluation of mineral properties in Quebec, Canada. More about Nouveau Monde Graphite

Market Capitalization: $231.59 million
Consensus Rating: Buy
Consensus Price Target: $4.67 (+222.0% Upside)
Volume: 308,977 shares
Average Volume: 372,215 shares
Today's Range: $1.43
▼
$1.52

4. iBio NASDAQ:IBIO

$1.36 -0.04 (-2.86%)

As of 08/28/2026 04:00 PM Eastern

iBio, Inc, a biotechnology company, provides contract development and manufacturing services to collaborators and third-party customers in the United States. More about iBio

Market Capitalization: $67.56 million
Consensus Rating: Buy
Consensus Price Target: $5.00 (+267.6% Upside)
Volume: 513,043 shares
Average Volume: 693,874 shares
Today's Range: $1.34
▼
$1.42

5. Galiano Gold NYSEAMERICAN:GAU

$2.29 -0.12 (-4.98%)

As of 08/28/2026 04:10 PM Eastern

Galiano Gold Inc engages in the exploration and evaluation of gold properties in Canada. Its flagship asset is the Asanko Gold Mine that covers an area of approximately 21,000 hectares located in Ghana, West Africa. More about Galiano Gold

Market Capitalization: $598.63 million
P/E Ratio: 6.74
Consensus Rating: Buy
Consensus Price Target: $4.25 (+85.6% Upside)
Volume: 3.51 million shares
Average Volume: 2.92 million shares

6. Palisade Bio NASDAQ:PALI

$2.00 -0.11 (-5.21%)

As of 08/28/2026 04:00 PM Eastern

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States. More about Palisade Bio

Market Capitalization: $348.54 million
Consensus Rating: Buy
Consensus Price Target: $9.00 (+350.0% Upside)
Volume: 2.13 million shares
Average Volume: 1.57 million shares
Today's Range: $1.99
▼
$2.11

7. Inhibikase Therapeutics NASDAQ:IKT

$2.41 -0.06 (-2.43%)

As of 08/28/2026 04:00 PM Eastern

Inhibikase Therapeutics, Inc, a clinical stage pharmaceutical company, develops therapeutics for Parkinson's Disease (PD) and related disorders that arise inside and outside of the brain. More about Inhibikase Therapeutics

Market Capitalization: $336.28 million
Consensus Rating: Buy
Consensus Price Target: $5.40 (+124.1% Upside)
Volume: 307,959 shares
Average Volume: 496,962 shares
Today's Range: $2.37
▼
$2.48

8. Compugen NASDAQ:CGEN

$2.60 -0.16 (-5.80%)

As of 08/28/2026 04:00 PM Eastern

Compugen Ltd., a clinical-stage therapeutic discovery and development company, researches, develops, and commercializes therapeutic and product candidates in Israel, the United States, and Europe. More about Compugen

Market Capitalization: $245.84 million
P/E Ratio: 6.84
Consensus Rating: Buy
Consensus Price Target: $5.00 (+92.3% Upside)
Volume: 228,795 shares
Average Volume: 369,876 shares

9. Stereotaxis NYSEAMERICAN:STXS

$1.45 -0.02 (-1.36%)

As of 08/28/2026 04:10 PM Eastern

Stereotaxis, Inc designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. More about Stereotaxis

Market Capitalization: $145.29 million
Consensus Rating: Buy
Consensus Price Target: $3.50 (+141.4% Upside)
Volume: 288,128 shares
Average Volume: 653,830 shares
Today's Range: $1.44
▼
$1.49

10. Equillium NASDAQ:EQ

$2.39 -0.06 (-2.45%)

As of 08/28/2026 04:00 PM Eastern

Equillium, Inc, a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory, or immuno-inflammatory disorders with unmet medical need. More about Equillium

Market Capitalization: $151.55 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.57 (+216.8% Upside)
Volume: 232,753 shares
Average Volume: 517,804 shares
Today's Range: $2.33
▼
$2.46

11. Ovid Therapeutics NASDAQ:OVID

$2.80 -0.13 (-4.44%)

As of 08/28/2026 04:00 PM Eastern

Ovid Therapeutics Inc, a biopharmaceutical company, engages in the development of impactful medicines for patients and families with epilepsies and seizure-related neurological disorders in the United States. More about Ovid Therapeutics

Market Capitalization: $546.83 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.71 (+104.1% Upside)
Volume: 1.67 million shares
Average Volume: 1.54 million shares
Today's Range: $2.76
▼
$2.93

12. Autolus Therapeutics NASDAQ:AUTL

$2.34 -0.02 (-0.85%)

As of 08/28/2026 04:00 PM Eastern

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases. More about Autolus Therapeutics

Market Capitalization: $622.82 million
Consensus Rating: Moderate Buy
Consensus Price Target: $10.00 (+327.4% Upside)
Volume: 1.44 million shares
Average Volume: 3.52 million shares
Today's Range: $2.28
▼
$2.36

13. Compass Therapeutics NASDAQ:CMPX

$2.40 -0.12 (-4.76%)

As of 08/28/2026 04:00 PM Eastern

Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass Therapeutics

Market Capitalization: $432.21 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.77 (+390.4% Upside)
Volume: 2.57 million shares
Average Volume: 3.21 million shares
Today's Range: $2.40
▼
$2.51

14. Nkarta NASDAQ:NKTX

$2.76 +0.01 (+0.36%)

As of 08/28/2026 04:00 PM Eastern

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization: $197.68 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.20 (+305.8% Upside)
Volume: 429,812 shares
Average Volume: 556,992 shares
Today's Range: $2.70
▼
$2.79

15. Tenaya Therapeutics NASDAQ:TNYA

$0.69 -0.01 (-0.73%)

As of 08/28/2026 04:00 PM Eastern

Tenaya Therapeutics, Inc, a biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. More about Tenaya Therapeutics

Market Capitalization: $154.74 million
Consensus Rating: Moderate Buy
Consensus Price Target: $4.00 (+479.6% Upside)
Volume: 1.11 million shares
Average Volume: 2.11 million shares
Today's Range: $0.69
▼
$0.70

16. NervGen Pharma NASDAQ:NGEN

$2.28 -0.06 (-2.56%)

As of 08/28/2026 04:00 PM Eastern

NervGen Pharma Corp., a biotechnology company, engages in the discovery, development, and commercialization of pharmaceutical treatments to promote nervous system repair in settings of neurotrauma and neurologic disease. More about NervGen Pharma

Market Capitalization: $183.84 million
Consensus Rating: Moderate Buy
Consensus Price Target: $14.00 (+514.0% Upside)
Volume: 868,928 shares
Average Volume: 490,898 shares
Today's Range: $2.24
▼
$2.40

17. Rani Therapeutics NASDAQ:RANI

$0.84 -0.01 (-1.66%)

As of 08/28/2026 04:00 PM Eastern

Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani Therapeutics

Market Capitalization: $117.09 million
Consensus Rating: Moderate Buy
Consensus Price Target: $8.75 (+941.7% Upside)
Volume: 371,367 shares
Average Volume: 716,756 shares
Today's Range: $0.84
▼
$0.86

18. High Tide NASDAQ:HITI

$2.51 -0.06 (-2.33%)

As of 08/28/2026 04:00 PM Eastern

High Tide Inc engages in the cannabis retail business in Canada, the United States, and internationally. The company operates through Retail and Wholesale segments. More about High Tide

Market Capitalization: $220.82 million
P/E Ratio: 62.75
Consensus Rating: Moderate Buy
Consensus Price Target: $5.63 (+124.1% Upside)
Volume: 334,466 shares
Average Volume: 476,766 shares

19. Tritax Big Box REIT OTCMKTS:TTBXF

$2.06 0.00 (0.00%)

As of 08/28/2026

Tritax Big Box REIT plc (ticker: BBOX) is the largest listed investor in high-quality logistics warehouse assets and controls the largest logistics-focused land platform in the UK. More about Tritax Big Box REIT

Market Capitalization: $5.57 billion
Consensus Rating: Moderate Buy
Average Volume: 73 shares
Today's Range: $2.06
▼
$2.06
50-Day Range: $1.98
▼
$2.43
52-Week Range: $1.70
▼
$2.43

20. Cellectar Biosciences NASDAQ:CLRB

$2.53 -0.01 (-0.39%)

As of 08/28/2026 04:00 PM Eastern

Cellectar Biosciences, Inc, a clinical biopharmaceutical company, focuses on the discovery, development, and commercialization of drugs for the treatment of cancer. More about Cellectar Biosciences

Market Capitalization: $23.91 million
Consensus Rating: Moderate Buy
Consensus Price Target: $11.00 (+334.8% Upside)
Volume: 23,826 shares
Average Volume: 34,701 shares
Today's Range: $2.51
▼
$2.55

21. Caribou Biosciences NASDAQ:CRBU

$1.62 -0.04 (-2.41%)

As of 08/28/2026 04:00 PM Eastern

Caribou Biosciences, Inc, a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies in the United States and internationally. More about Caribou Biosciences

Market Capitalization: $173.68 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.75 (+378.4% Upside)
Volume: 666,561 shares
Average Volume: 1.03 million shares
Today's Range: $1.60
▼
$1.67

22. Data I/O NASDAQ:DAIO

$2.93 -0.05 (-1.68%)

As of 08/28/2026 04:00 PM Eastern

Data I/O Corporation, together with its subsidiaries, engages in the design, manufacture, and sale of programming and security deployment systems and services for electronic device manufacturers in the United States, Europe, and internationally. More about Data I/O

Market Capitalization: $27.53 million
Consensus Rating: Moderate Buy
Consensus Price Target: $5.11 (+74.4% Upside)
Volume: 27,042 shares
Average Volume: 43,163 shares
Today's Range: $2.93
▼
$3.10

23. Tvardi Therapeutics NASDAQ:TVRD

$1.82 +0.02 (+1.11%)

As of 08/28/2026 04:00 PM Eastern

Cara Therapeutics, Inc, an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. More about Tvardi Therapeutics

Market Capitalization: $24.28 million
Consensus Rating: Moderate Buy
Consensus Price Target: $18.00 (+889.0% Upside)
Volume: 337,255 shares
Average Volume: 201,052 shares
Today's Range: $1.78
▼
$1.92

24. Connect Biopharma NASDAQ:CNTB

$2.23 -0.05 (-2.19%)

As of 08/28/2026 04:00 PM Eastern

Connect Biopharma Holdings Limited, a clinical-stage biopharmaceutical company, engages in the development of therapies for the treatment of T cell-driven inflammatory diseases. More about Connect Biopharma

Market Capitalization: $140.43 million
Consensus Rating: Moderate Buy
Consensus Price Target: $7.43 (+233.1% Upside)
Volume: 339,135 shares
Average Volume: 442,489 shares
Today's Range: $2.20
▼
$2.32

25. Inovio Pharmaceuticals NASDAQ:INO

$1.29 +0.03 (+2.38%)

As of 08/28/2026 04:00 PM Eastern

Inovio Pharmaceuticals, Inc, a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. More about Inovio Pharmaceuticals

Market Capitalization: $133.38 million
Consensus Rating: Moderate Buy
Consensus Price Target: $3.17 (+145.5% Upside)
Volume: 1.70 million shares
Average Volume: 5.45 million shares
Today's Range: $1.26
▼
$1.32

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Best Stocks Under $3 Right Now

1. Ur Energy NYSEAMERICAN:URG

2. CuriosityStream NASDAQ:CURI

3. Nouveau Monde Graphite NYSE:NMG

4. iBio NASDAQ:IBIO

5. Galiano Gold NYSEAMERICAN:GAU

6. Palisade Bio NASDAQ:PALI

7. Inhibikase Therapeutics NASDAQ:IKT

8. Compugen NASDAQ:CGEN

9. Stereotaxis NYSEAMERICAN:STXS

10. Equillium NASDAQ:EQ

11. Ovid Therapeutics NASDAQ:OVID

12. Autolus Therapeutics NASDAQ:AUTL

13. Compass Therapeutics NASDAQ:CMPX

14. Nkarta NASDAQ:NKTX

15. Tenaya Therapeutics NASDAQ:TNYA

16. NervGen Pharma NASDAQ:NGEN

17. Rani Therapeutics NASDAQ:RANI

18. High Tide NASDAQ:HITI

19. Tritax Big Box REIT OTCMKTS:TTBXF

20. Cellectar Biosciences NASDAQ:CLRB

21. Caribou Biosciences NASDAQ:CRBU

22. Data I/O NASDAQ:DAIO

23. Tvardi Therapeutics NASDAQ:TVRD

24. Connect Biopharma NASDAQ:CNTB

25. Inovio Pharmaceuticals NASDAQ:INO

More Stock Ideas from MarketBeat

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Best Stocks Under $3 Right Now

More Stock Ideas from MarketBeat

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools